Lyme disease infection imprints long-term changes in immune cells

A new study led by researchers at Tufts University School of Medicine suggests that infection with Borrelia burgdorferi, the bacterium that causes Lyme disease, can leave lasting changes in the immune system, even after the infection is treated. The changes occur in the bone marrow, where many of the body's immune cells are made, potentially altering how the immune system responds to future threats.

The findings, published in iScience, offer new clues into how an infection might have effects that persist after the bacteria are gone. The researchers say the work ultimately could help identify biological markers associated with prolonged symptoms after Lyme disease and point to potential treatment targets.

A lifetime of infections and inflammatory exposures creates little editing marks, called epigenetic changes, in the immune system's record of all it has encountered so far. Our study found that epigenetic changes in the bone marrow imprinted by Borrelia burgdorferi infection may essentially revise the immune system's 'biography' and how it responds over time."

Tanja Petnicki-Ocwieja, study's senior author and research assistant professor of molecular biology and microbiology, School of Medicine, Tufts University

To investigate the long-term effects of Lyme disease, the researchers used a mouse model to examine bone marrow cells after an infection, including in mice that subsequently received antibiotics. They found that Borrelia burgdorferi infection produced distinct epigenetic changes—chemical modifications that can influence which genes are turned on or off—in bone marrow cells.

The effects were particularly apparent in macrophages, immune cells produced in the bone marrow that serve as early responders to infection. Macrophages detect potential threats, surround invading microbes, and release chemical signals that summon other immune cells to attack the invaders.

Macrophages produced by mice previously exposed to Borrelia burgdorferi showed suppressed expression of genes involved in this inflammatory response for at least 15 weeks after infection.

"When macrophages first encounter Borrelia burgdorferi, they sound alarm bells that tell other immune cells to come destroy the bacteria," Petnicki-Ocwieja said. "But after these epigenetic changes are imprinted in the bone marrow, the macrophages appear to sound fewer of those alarms."

Notably, an altered immune response also was seen in mice that received antibiotics, suggesting that some changes can occur relatively early during infection and do not require a prolonged or ongoing bacterial illness.

"This suggests that an individual's first exposure to Borrelia burgdorferi is enough to cause long-term effects on the immune response," said Yuelin Zhong, a PhD student in immunology at the Graduate School of Biomedical Sciences and the study's first author.

The findings do not establish that these immune changes occur in people with Lyme disease or that they cause persistent symptoms. To determine whether the changes are relevant to human illness, the researchers next want to examine epigenetic markers in people after a Lyme disease infection.

Petnicki-Ocwieja will collaborate with co-author Linden Hu, the Paul and Elaine Chervinsky Professor of Immunology at the School of Medicine, to analyze immune cells circulating in blood from a large multi-institution study led by Tufts that follows patients for up to 15 months after a Lyme disease diagnosis.

The researchers hope this work will help determine whether people who develop prolonged symptoms have different epigenetic patterns from those who recover without lasting symptoms.

"My hope is to sequence these epigenetic marks to create profiles of what Lyme disease does to an individual's immune system," Petnicki-Ocwieja said. "We can then use that to see if the profiles belonging to patients who have long-term symptoms look different from patients who have successfully recovered."

If such differences are found, they could provide clues about why some people continue to experience symptoms after Lyme disease treatment—and potentially help researchers identify biomarkers for prolonged illness or new ways to treat this persistent fatigue, joint pain, or cognitive difficulties.

Source:
Journal reference:

Zhong, Y., et al. (2026). Borrelia burgdorferi infection induces characteristic reprogramming in bone marrow cells. iScience. DOI: 10.1016/j.isci.2026.118281. https://www.cell.com/iscience/fulltext/S2589-0042(26)03664-3

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Genetic barcoding tracks human stem cells to improve bone marrow transplant